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Abstract Signal transduction at vertebrate excitatory synapses involves the rapid activation of
AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionate) receptors, glutamate-gated ion
channels whose four subunits assemble as a dimer-of-dimers. Technical advances in cryo-electron
microscopy brought a slew of full-length structures of AMPA receptors, on their own and in
combination with auxiliary subunits. These structures indicate that dimers might undergo
substantial lateral motions during gating, opening up the extracellular layer along the central
twofold symmetry axis. We used bifunctional methanethiosulfonate cross-linkers to calibrate the
conformations found in functional AMPA receptors in the presence and absence of the auxiliary
subunit Stargazin. Our data indicate that extracellular layer of AMPA receptors can get trapped in
stable, opened-up conformations, especially upon long exposures to glutamate. In contrast,
Stargazin limits this conformational flexibility. Thus, under synaptic conditions, where brief
glutamate exposures and the presence of auxiliary proteins dominate, extracellular domains of
AMPA receptors likely stay compact during gating.
DOI: https://doi.org/10.7554/eLife.40548.001
Introduction
AMPA-type glutamate receptors are found at excitatory synapses throughout the mammalian brain,
where they convert glutamate release into membrane depolarization. Their fast kinetics
(Colquhoun et al., 1992; Geiger et al., 1995; Taschenberger and von Gersdorff, 2000), as well as
the physical attributes of synapses (Xu-Friedman and Regehr, 2003), allow them to follow gluta-
mate transients at rates above 100 Hz. However, the structural dynamics underlying their rapid sig-
naling are unclear.
AMPA receptors are tetrameric ligand-gated ion channels. Ignoring their intracellular regions,
they consist of three layers formed from distinct domains (Figure 1A). The two extracellular layers
assemble from amino-terminal domains and ligand-binding domains, ATDs and LBDs, respectively.
These adopt local dimer pairs in resting and active receptors. These dimers pack around a central
twofold symmetry axis that switches into fourfold symmetry in the transmembrane ion channel layer.
Although the ATD dimers associate with high affinity (KD nM to mM (Zhao et al., 2017), the associa-
tion of ATD dimers into a tetramer as well as of LBDs into dimers and tetramers is too weak to mea-
sure. In case of the LBDs, this weak association has direct functional consequences, because the LBD
intra-dimer interface ruptures upon desensitization (Sun et al., 2002; Armstrong et al., 2006;
Du¨rr et al., 2014; Twomey et al., 2017b).
The crowded and narrow synaptic cleft is scarcely wider than the receptors are tall themselves
and has narrow edges (Zuber et al., 2005; Tao et al., 2018). This observation suggests that confor-
mational dynamics of the receptor domains and their relation to synapse dimensions has implications
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in both health and disease. For example, if the extracellular layer of AMPA receptors can undergo
large conformational changes rapidly, that is on the millisecond timescale of fast excitatory transmis-
sion, this could disrupt possible interactions of the extracellular domains with the pre- and postsyn-
aptic anchoring proteins (Elegheert et al., 2016). Activity-dependent anchoring might be a way to
regulate synaptic strength (Constals et al., 2015). On the other hand, slow rearrangements could
be relevant for trafficking, and in disease states.
Advances in the structural biology of ionotropic glutamate receptors (iGluRs) have produced a
catalogue of static conformational snapshots. Several agonist-bound structures (Nakagawa et al.,
2005; Du¨rr et al., 2014; Meyerson et al., 2014) suggest that local dimers in the ATD and LBD layer
move apart from each other substantially. This movement away from the central twofold symmetry
axis results in an ‘open’ extracellular layer, with the tops of the ATD and LBD dimers splaying wide
open (desensitized structure in Figure 1A). The timescale of this broad lateral movement is
unknown, because the structural experiments necessarily took place over hours. We therefore set
out to investigate the conformational range of agonist-bound AMPA receptors with the aim of dis-
tinguishing frequently-visited, short-lived conformations from the long-lived ones that likely have less
direct relevance to synaptic transmission.
Previously, we demonstrated disulphide bonds and metal bridges trapping receptors in compact,
as opposed to ‘open’ LBD arrangements (Salazar et al., 2017; Baranovic et al., 2016; Lau et al.,
2013). To measure the separation of domains in this work, we used bifunctional methanethiosulfo-
nate cross-linkers (bis-MTS) of defined lengths (Loo and Clarke, 2001; Guan et al., 2002;
Armstrong et al., 2006; Tajima et al., 2016) (Figure 1D). These cross-linkers show specific combi-
nation with two free thiol groups, provided by cysteine residues that we engineered. The selective
reactivity of a series of probes can in principle report distances, giving them the property of
eLife digest The nearly 100 billion neurons in our brain create a complex and intricate network
that can relay information in a fraction of a second. Two neurons can communicate with each other
by forming a synapse, a specialised structure where the two cells come into close contact. There, the
signalling neuron releases chemicals that the receiving cell captures through dedicated receptors
embedded in its membrane. For example, the AMPA receptor is a complex assemblage of different
subunits that quickly transmits information by opening and closing to let ions move into the
receiving cell. These receptors are some of the fastest to react to the released chemicals, allowing
information to be encoded swiftly. In fact, it is increasingly clear that epilepsy and deficits in mental
processes can be associated with AMPA receptors having a faulty activity.
Yet, it is still unknown how exactly these proteins work. In particular, previous studies have shown
that an AMPA receptor can go through dramatic changes in its structure, with the different subunits
being able to spread apart widely. However, these experiments had to be conducted when the
proteins were isolated from membranes and held in a cocktail of activating or deactivating
molecules for hours. It is still unclear whether the results hold when AMPA receptors sit at the
membrane while assembled with their partner proteins, like they normally do in the brain.
Baranovic and Plested went on to investigate this question by using ‘molecular rulers’. These tiny
molecules have different lengths, and they act as yardsticks: their sticky ends can attach to specific
areas in the protein, helping to measure how these regions move relative to each other when the
receptors are on or off. A method called patch clamp electrophysiology was used to determine how
much the normal activity of the AMPA receptors was hindered by being bound by the molecular
rulers.
The results showed that AMPA receptors can undergo large structural changes but these
movements require time and are much reduced by partner proteins. In the brain, AMPA receptors in
synapses probably lack the freedom and opportunity to move so dramatically when neurons are
communicating with each other.
Ultimately, knowing how these receptors work and move may help grasp the changes in their
activity that cause connections between neurons to become defective.
DOI: https://doi.org/10.7554/eLife.40548.002
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Figure 1. Geometry of AMPA receptors. (A) Structures of full-length AMPA receptors in resting, active and desensitized states. Accesion codes for PBD
or EMDB are indicated. Subunits are color-coded: A – green, B – red, C – blue and D – yellow. Brackets delineate AMPA receptor domains: ATDs –
amino terminal domains, LBDs – ligand binding domains and TM – transmembrane region. The cytoplasmic domain is not resolved. Vertical, dashed
lines indicate central twofold symmetry axis. The corresponding LBDs are shown in the bottom-up view. Double-headed arrows indicate movements of
Figure 1 continued on next page
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nanometre-scale molecular rulers. Based on activated and desensitized state structures, we reasoned
that, crosslinking between ligand binding domain dimers should be state-dependent. Short cross-
linkers should be favored in active states with compact LBD layers, and longer crosslinkers should be
favored in desensitized states.
Our results suggest that the more opened-up a given conformation of the extracellular layer of
the receptor is, the slower it is to access. Once attained, these conformations are stable. However,
auxiliary subunits restrict the conformational ensemble, maintaining more compact arrangements of
the LBD layer, without much separation of the two LBD dimers. This kinetic classification suggests
AMPA receptors at synapses probably have similar, compact geometries regardless of their instanta-
neous gating state.
Results
The LBD layer opens up in desensitized AMPA receptors
The rupture of the LBD intra-dimer interface is a structural hallmark of AMPA receptor desensitiza-
tion, as shown by biophysical studies based on the structures of isolated ligand binding domains
(Sun et al., 2002; Armstrong et al., 2006). Several cryo-electron microscopy (cryo-EM) structures of
full-length receptors (Nakagawa et al., 2005; Du¨rr et al., 2014; Meyerson et al., 2014), such as
the one shown in Figure 1A, suggest that desensitization might involve further rearrangements of
the ligand-binding domains, including movement of the two LBD dimers away from the central two-
fold axis of symmetry and an even more substantial ‘opening’ of the ATD-layer parallel to the mem-
brane plane.
We attempted to capture this movement between LBDs with bis-MTS cross-linkers ranging from
7 to 18 A˚ in length (Figure 1D). If the LBD layer is opened up in the horizontal plane upon receptor
desensitization, this movement should create access for bis-MTS cross-linkers into the inter-dimer
space (orange spheres in Figure 1A). Because bis-MTS cross-linkers are flexible (apart from bMTSp,
which is rigid), they can bend and bind to Cys residues whose separation is shorter than the length
of the cross-linker. Here, we assume that a fully reacted cross-linker will exert its effect mainly by pre-
venting the engineered residues from separating more than the extended length of the cross-linker
(Figure 1D). Conversely, if the two free Cys residues never separate beyond the length of the cross-
linker during gating, then the cross-linker should have little or no effect.
The ability of the cross-linkers of different lengths to access the inter-dimer space in the LBD layer
reports on the lateral separation of the two LBD dimers, but does not inform the movements the
LBD layer undertook to arrive at the specific conformation. We can assume that the membrane-
bound TM region somewhat restricts vertical displacement of the LBDs. Thus, the movements we
are probing are those approximately parallel to the membrane. The cross-linkers could in principle
be applied to the ATDs, but ATD layer is functionally silent (Pasternack et al., 2002) and its cross-
linking does not produce measurable changes in the receptor activity (Yelshanskaya et al., 2016).
We, therefore, do not make any extrapolations here about the ATD movements from cross-linking
the LBD layer, but structural models and fluorescence studies (Shaikh et al., 2016) so far indicate
that the ATDs do follow movements of the LBD layer (Figure 1A–B).
Based on the structural models of homomeric, full-length GluA2 receptors, we identified positions
665 and 666 (in the loop connecting a-helices F and G in the LBDs) as best positioned to follow
Figure 1 continued
dimers in the extracellualr layer. Each orange sphere indicates position of residues 665 and 666 (mutated individually in this study). In subunits A and C,
the mutated residues are facing each other across the LBD inter-dimer interface, whereas in subunits B and D, they are located on the outer surface of
the protein. Based on the structures, the mutated residues could cross-link across subunits A and C, as symbolized by the double dashed lines for the
functional states studied here. The measured distances are shown in (C). Details are omitted for the desensitized structure (2688) due to its low
resolution. (B) Same as in (A) but for GluA2 structures complexed with auxiliary subunits: Stg – Stargazin (dark purple) and GSG1L (light purple). (C)
Distances between sulfhydryl groups (orange) of individually mutated residues, A665C and V666C, in agonist-bound strucures shown in panels A and B.
(D) Structures of bifunctional (bis-MTS: M1M-M10M) and monofunctional (MTSEA) compounds. Lengths were measured between reactive sulphur
atoms (SG, asterisks).
DOI: https://doi.org/10.7554/eLife.40548.003
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separation of the LBD dimers (Figure 1A–C). The presumptive geometries of the sulfhydryl groups
(SG) for cysteine mutants at these sites, in the agonist bound states of GluA2 receptor (with and
without auxiliary subunits) are shown in Figure 1C. The structure of the desensitized GluA2 receptor
(EMDB: 2688, Figure 1A) is not detailed enough to measure residue distances, but the equivalent
residues are 21 A˚ apart in homologous kainate receptors (PDB: 5KUF; Meyerson et al., 2016).
Based on these structural data, all six bis-MTS cross-linkers should be able to modulate desensitized
V666C and A665C receptors by preventing engineered Cys at both sites from reaching their full sep-
aration in the desensitized state, in the absence of auxiliary subunits. Given the distances in pub-
lished structures, one might expect M10M to stabilize active V666C receptors in the absence of
auxiliary subunit Stargazin and M8M in its presence (Figure 1C–D).
As shown in Figure 2B and D, bis-MTS cross-linkers M1M to M10M all caused strong reduction
of the peak current in V666C mutant when applied in the desensitized state. To quantify this effect,
the peak current was measured from the control pulses before (Ipeak pre-trap, four pulses) and after
the 1 min application (trap) of the cross-linker (Ipeak post-trap, second control pulse after the trap,
arrows in Figure 2A–C). For each patch, the ratio of Ipeak post-trap over Ipeak pre-trap was deter-
mined and plotted as shown in Figure 2D–E.
For the V666C mutant, bis-MTS cross-linkers from 7 to 15 A˚ in length (M1M-M8M; 1 mM),
inhibited ~90% of the peak current in the patch after a 1-min application (Figure 2—source data 1).
The longest (M10M) cross-linker was the slowest one to act (Figure 2F), leading to less inhibition
(~70%) in the first minute of exposure. The reduction was less pronounced for A665C mutant for all
cross-linkers (~50%, Figure 2E and Figure 2—source data 1).
The slow reaction time of bis-MTS cross-linkers (minute, Figure 2F) is a direct consequence of
their low concentration (1 mM). We chose a low concentration in order to minimize the linking of
these highly reactive compounds to each other (Kenyon and Bruice, 1977). However, the slow
action of bis-MTS cross-linkers could also be due to the sampling of slowly attained conformations.
To determine that modification of the V666C receptors by MTS cross-linkers can proceed on the
same time scale as receptor gating, we performed additional trapping experiments with 50 mM
M3M and M10M (Figure 3). If the slow reaction rate of bis-MTS is primarily due to their low concen-
tration, the reaction time should increase accordingly at higher concentrations. Indeed, at 50 mM,
both bis-MTS cross-linkers were roughly 50x faster to modify the receptors (tM3M = 0.2 s and tM10M
= 1.7 s, Figure 3B and D). The relative modification time was preserved with the longer cross-linker
(M10M) still being slower than the shorter one (M3M). These experiments indicate that bifunctional
MTS reagents are capturing rapid transitions in receptor structure on the millisecond timescale.
Inhibition was overall so profound that we sought to establish that it was specific. Two other fac-
tors potentially contribute to the current decrease: non-specific run-down of the current and disul-
phide bonding of the introduced cysteines to each other. Current run-down is particularly difficult to
avoid in the long records that we made for these experiments. A665C and V666C sulfhydryl groups
were both previously shown to crosslink in the presence of oxidizing agent CuPhen (Salazar et al.,
2017; Lau et al., 2013; Yelshanskaya et al., 2016). To account for these confounding factors, we
made paired recordings: a patch was first exposed to a 1-min long trapping pulse containing gluta-
mate only (no cross-linkers), followed by trapping of the same patch in glutamate and a cross-linker
(Figure 2B–C). Any run-down in the patch or possible cross-linking of the cysteines to each other
was then assessed from trapping in glutamate only. In case of A665C, the introduced cysteines
linked to each other during long exposures to 10 mM glutamate, resulting in the peak current reduc-
tion of 0.62 ± 0.04 (n = 23, p < 10 7 vs. WT: 0.97 ± 0.03, n = 30), consistent with previous results
(Lau et al., 2013; Yelshanskaya et al., 2016). In reducing conditions, the trapped A665C receptors
recovered within seconds (grey dots in Figure 2C, t = 3.3 ± 0.4 s, n = 17). V666C mutant underwent
less peak current inhibition during exposures to 10 mM glutamate (V666C: 0.86 ± 0.02, n = 44,
p = 0.003 vs. WT) and showed no evidence of recovery in reducing conditions. For V666C mutant,
all six bis-MTS cross-linkers resulted in more current inhibition than glutamate alone (p  0.03 with
and without bis-MTS, depending on the cross-linker; paired randomization test). Overall, paired
recordings gave indistinguishable results to the non-paired recordings. We therefore pooled the
cross-linking data in glutamate alone across conditions for each mutant (Figure 2D–E and Figure 2—
source data 1).
To confirm that the observed peak current reduction came from crosslinking rather than mono-
functional engagement of a cross-linker, we modified mutants with MTSEA (Figure 1D), which can
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Figure 2. LBDs can separate 18 A˚ in desensitized GluA2. (A) Control recording of wild-type (WT) GluA2 receptors in response to a trapping protocol.
Movements of the piezo reflecting the solution exchange are shown in thin, black lines above the current trace. Composition of the solutions is
indicated in thick lines above the piezo trace. Downward ticks are 200 ms control jumps from DTT (1 mM) to DTT and glutamate (Glu, 10 mM). Four
pre-trap control pulses were followed by a 1 min long trapping pulse (red line) in Glu (10 mM) and M3M (1 mM). After the trapping pulse, the patch was
exposed to 10 post-trap control pulses. The first post-trap pulse gives no response because receptors are desensitized (for details, see Materials and
Figure 2 continued on next page
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interact only with a single cysteine. As shown in Figure 2D–E, MTSEA failed to inhibit either V666C
or A665C above Glu-only control (V666C: 0.74 ± 0.008, n = 4, p = 0.1; A665C: 0.81 ± 0.06, n = 4,
p = 0.06). Thus, bifunctional MTS cross-linking was necessary for the peak current reduction
observed in desensitizing AMPA receptors.
The effect of all bis-MTS cross-linkers with respect to their length is summarized in the trapping
profile for desensitized V666C receptors (Figure 2G). The profile is a shallow parabola with strong
effects across all tested lengths. Fitting a parabola to these data is justified by the observation that
direct disulphide crosslinking (representing the short distance limit) is quite ineffective at this site
(Figure 2D and Lau et al., 2013). These results demonstrate that limiting V666C separation of
desensitized AMPA receptors to 18 A˚ causes inhibition, indicating further separation of the residues
is possible, in good agreement with cryo-EM structures (Meyerson et al., 2014; Du¨rr et al., 2014).
In addition to positions 665 and 666, we also tested nearby positions 662 and 664 for their sensi-
tivity to bis-MTS cross-linkers (Figure 2—figure supplement 1). The I664C mutant showed similar
levels of the peak current reduction to V666C. However, structural models position V666C sulfhydr-
yls at distances that are better matched by the length of bis-MTS cross-linkers (Figure 1C–D) than
the separation of I664C sulfhydryls across different functional states (Figure 2—figure supplement
1A). Like the A665C mutant, the S662C mutant showed considerable disulphide formation. For
these reasons, we focused on the V666C mutant in further investigations.
Next, we tested if the cross-linkers specifically target introduced cysteines. We utilized the estab-
lished phenomenon that restraining the LBD intra-dimer interface leads to block of desensitization
(Sun et al., 2002; Armstrong et al., 2006). If the bis-MTS cross-linkers specifically target intra-dimer
interface, then introducing a single cysteine mutant, positioned within LBD dimers (Figure 2—figure
supplement 2A), such as K493C (Armstrong et al., 2006), should lead to a block of desensitization
depending on the length of the cross-linker. Sulfhydryl groups of K493C residues in resting and
active GluA2 receptors with intra-dimer LBD interface intact are 7 and 6 A˚ apart, respectively (as
measured in the following resting: 3KG2, 4U2P, 5L1B and active structures: 4UQ6, 5WEO, using the
most common rotamers). The desensitized structure in complex with the auxiliary subunit GSG1L has
K493C residues 12 A˚ apart (5VHZ). It has been previously shown that sulfhydryl groups of residues
Figure 2 continued
methods). (B) Same as in (A), but for V666C mutant. The top two recordings are from the same patch: in the first trace, V666C receptors were exposed
only to Glu. Trapping of the same patch in Glu and M1M (1 mM), results in pronounced peak current reduction, which partly recovered with trecovery =
30 ± 7 s, n = 5 (grey dots; post-trap control pulses extended to 30 for fit). The bottom trace is a different patch trapped in bMTSp (1 mM), showing even
stronger peak current reduction without any recovery. (C) As in (B) but for the A665C mutant. The two traces are paired recordings of the same patch.
Post-trap control pulses show that A665C cross-links to itself, but most of the current recovers within several seconds after the trap (grey dots; trecovery
= 3.3 ± 0.4 s, n = 17). If the same patch is now trapped in Glu and M8M (1 mM), the peak current reduction is much more pronounced and does not
recover. (D) Summary of the trapping effects for WT (black) and V666C (red) for cross-linkers M1M (7 A˚) to M10M (18 A˚). Trapping effect after 1 min was
calculated as the ratio of the post-trap and pre-trap peak current (arrows in A-C). MTSEA is a monofunctional reagent and ‘w/o MTS’ stands for ‘without
MTS’ (Glu only, pooled for all experiments). Dashed line indicates no effect. For peak current reduction in a bis-MTS vs. w/o MTS (pooled), p < 10 7, for
all cross-linkers. (E) Same as in (D), but for A665C (red) in cross-linkers M3M (9 A˚) to M10M (18 A˚). A665C mutant in the presence and absence of an
MTS cross-linker resulted in p  0.02, depending on the cross-linker. For statistics vs. WT and between different bis-MTS, see Figure 2—source data 1.
(F) Trapping time for V666C receptors in M3M, M6M and M10M. The 1-min trapping protocol was repeated up to six times, resulting in a cumulative
exposure of the patch to a bis-MTS of up to 6 min. The data were fit with a monoexponential for each cross-linker (t indicated in brackets). (G) Trapping
profile of desensitized V666C receptors shows the effect of each cross-linker vs. its length, in the first minute of exposure. The data were fit with a
parabola (red line): f(x) = K0 + K1*(x – K2)
2 (for details, see Materials and methods).
DOI: https://doi.org/10.7554/eLife.40548.004
The following source data and figure supplements are available for figure 2:
Source data 1. Statistics of trapping desensitized wild-type (WT), A665C and V666C receptors with different bis-MTS cross-linkers; data from
Figure 2D–E.
DOI: https://doi.org/10.7554/eLife.40548.008
Figure supplement 1. Effects of bis-MTS cross-linkers on S662C and I664C mutants.
DOI: https://doi.org/10.7554/eLife.40548.005
Figure supplement 2. Bis-MTS cross-linkers potentiate K493C currents by accessing intra-dimer space.
DOI: https://doi.org/10.7554/eLife.40548.006
Figure supplement 3. Bis-MTS compounds do not form inter-receptor cross-links.
DOI: https://doi.org/10.7554/eLife.40548.007
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K493C, in the absence of auxiliary subunits, must separate more than 13 A˚ for the LBD dimers to
desensitize (Armstrong et al., 2006). Based on these numbers, cross-linkers that are  13 A˚ in
length (M1M, M3M, bMTSp and M6M) are expected to block desensitization. When applied on
K493C receptors (1 mM, for  min), bis-MTS cross-linkers had profoundly different effect from the
mutants at the inter-dimer interface: they potentiated rather than inhibited the current (Figure 2—
figure supplement 2B–D). M1M blocked desensitization, as expected, although not completely
(Isteady-state/Ipeak = 49.6 ± 4%, n = 4, p = 0.006 vs. K493C desensitization levels in the absence of bis-
MTS: 26.6 ± 2%, n = 50). At 9 A˚, M3M was the most effective in blocking desensitization (Isteady-state/
Ipeak = 80.8 ± 2%, n = 16, p < 10
 7 vs. bis-MTS-free desensitization). M6M cross-linker blocked
desensitization, as predicted (Isteady-state/Ipeak = 63.7 ± 7%, n = 9, p < 10
 7 vs. bis-MTS-free desensiti-
zation), but rigid bMTSp at 12 A˚ failed to block desensitization (Isteady-state/Ipeak = 22.3 ± 1%, n = 7,
p = 0.5 vs. bis-MTS-free desensitization). As expected, none of the longer cross-linkers (M8M and
M10M) reduced desensitization compared to the non-treated K493C receptors (M8M: 18.3 ± 3%,
n = 9 and M10M: 40.3 ± 6%, n = 3, p 0.1 for both). Although bMTSp and M8M did not reduce
desensitization, they both potentiated K493C currents (they increased steady-state and peak current
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intervals in Ringer solution. (B) Progression of the peak current reduction in response to the trapping pulses (red in (A)) was determined for each patch,
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to the same extent, Figure 2—figure supplement 2B), unlike M10M cross-linker, which produced
no change in K493C currents. The absence of the effect for M10M could be either because it is too
long to bind to K493C receptors or because, even when bound, its length does not restrict move-
ments of desensitizing LBD monomers at position 493. The bis-MTS length-dependent block of
desensitization in K493C receptors strongly indicates the cross-linkers target introduced Cys muta-
tions selectively.
We also considered the possibility that bis-MTS cross-linkers might be spuriously cross-linking to
wild-type cysteines on the receptor or forming inter-receptor cross-links (Figure 2—figure supple-
ment 3A). If this were the case, the peak current reduction effect would be expected to scale with
the number of the receptors in the membrane, that is peak current, but no such correlation was
found (Figure 2—figure supplement 3B). In addition, longer cross-linkers would be expected to be
more efficient in forging inter-receptor cross-links, but we found that the longest cross-linker,
M10M, was the slowest to react on desensitized AMPA receptors (Figure 2F). The absence of the
strong peak current reduction in the WT receptors also speaks against the bis-MTS cross-linkers
interacting with native cysteine residues. These results led us to conclude that the bis-MTS cross-link-
ers can cross-link cysteines introduced at the LBD inter-dimer interface (V666C).
Cross-linked desensitized states are highly stable
Upon establishing specific and strong reduction of the peak current in desensitizing V666C receptors
by the bis-MTS cross-linkers, we next sought to examine the stability of trapped states. The more
stable the trapped state, the longer we would expect that it takes for trapping effects to reverse,
and vice versa. The fastest recovery after trapping was observed with M1M (t = 30 ± 7 s, n = 5) and
the time constant of the peak current recovery could be measured by directly fitting the peak cur-
rent of the post-trap control pulses (grey dots in Figure 2B). With longer bis-MTS cross-linkers, the
recovery time increased to minutes, making direct measurements of the recovery time from post-
trap control pulses impractical. Instead, the experimental design was adjusted to allow measure-
ments of long recovery times as described in Materials and methods and Figure 4. After the recep-
tors were trapped with M3M for 1 min, the peak current in the patch did recover, but very slowly,
taking over 10 min (600 applications of Glu) to reach the pre-trapping levels. With longer cross-link-
ers, the peak current was essentially irreversible over the timescales we could measure (20 min;
Figure 4D–G). The progressive inability of the receptors to recover from trapping with longer cross-
linkers indicates increasingly stable trapped states corresponding to greater separation of the cross-
linked subunits in the desensitized state (Figure 4G–H). Desensitized AMPA receptors with a disul-
phide bridge formed between the two V666C residues at inter-dimer interface fit in well with this
trend, recovering in seconds following 100 s exposure to the oxidizing agent CuPhen (Figure 4H).
Multiple stable desensitized states trapped by bis-MTS are a possible explanation for the low-resolu-
tion cryo-EM structures of desensitized AMPA receptors in the absence of auxiliary subunits
(Meyerson et al., 2014; Du¨rr et al., 2014).
To ensure that the lack of recovery was not due to a limited reducing capacity, we tested a higher
concentration of the reducing agent DTT (5 mM instead of 1 mM). Stronger reducing conditions did
not consistently promote recovery of V666C receptors trapped by a long cross-linker M6M (12 A˚;
p = 0.3, Figure 4—figure supplement 1).
Activation limits conformational heterogeneity of the LBD layer
We next investigated if the extracellular layer of activated V666C receptors is also accessible to a
similarly wide range of bis-MTS cross-linkers. According to the cryo-EM structure of AMPA receptor
in complex with glutamate and a desensitization blocker (Meyerson et al., 2014) (Figure 1C),
V666C residues are 19 A˚ apart and therefore we reasoned that all six cross-linkers should restrain
the receptor with M10M (18 A˚) expected to stabilize the active conformation.
To maintain the active state, we blocked desensitization with cyclothiazide (CTZ, 100 mM). As
shown in Figure 5, block of desensitization reduced inhibition by bis-MTS cross-linkers in the first
minute of exposure (see Figure 5 – source data 1for statistics). Current inhibition for every cross-
linker in the presence and absence of desensitization is shown in Figure 5B. With M1M, about 15%
of V666C receptors recovered from inhibition with a time constant of t = 7.1 ± 1 s, n = 4, leading to
the final inhibition of 0.65 ± 0.02, n = 12 (not shown). For M3M, the recovery was still faster with
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Figure 4. Recovery of trapped desensitized V666C receptors depends on the LBD separation. (A) To obtain a stable baseline response to glutamate,
we first repeated brief glutamate applications in reducing conditions (1 mM DTT). In the given example, we gave 17 pulses (100 ms, 1 Hz). (B) In the
following step, the patch was exposed to 1 mM cross-linker (here M3M) and 10 mM Glu for 1 min, with control pulses before and after the trap. (C) After
the trapping protocol, the patch was again exposed to fast, reducing Glu jumps like in (A) in order to follow recovery of the response. In this example,
we could record 1230 consecutive episodes (~20 min) and obtain almost complete recovery. Note the difference between the current amplitude in the
1st episode (grey) and the 1230th episode (red). The recovery of the patch current (Ipeak) in typical experiments for different cross-linkers is plotted in
panels D - F (panel E is the same patch as in panels A - C). Black dots show the responses before the trap and red dots the peak current after the trap.
The gap in red dots in (D) represents a switch between recording protocols. (G) Summary of the peak current recovery for different cross-linkers. The
percentage of recovered current is the ratio of the peak currents recorded 3–10 min after the trap to the peak current before trapping. Dashed, red line
denotes a limit after which no recovery of the current could be measured within 10 min after the trap. (H) Plot of recovery time from trapped
desensitized states (as described above and in Materials and methods) vs. the inter-dimer separation at position V666C in the LBD layer. The first data
point indicates recovery from V666C disulphide bridges formed in desensitized state.
DOI: https://doi.org/10.7554/eLife.40548.010
The following figure supplement is available for figure 4:
Figure supplement 1. Stronger reducing conditons do not increase recovery of desensitized V666C receptors trapped by M6M.
Figure 4 continued on next page
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t = 1.98 ± 0.2 s, n = 8 (grey dots in Figure 5A), with about 15% the receptors recovering and lead-
ing to the final inhibition of 0.53 ± 0.03, n = 9. The fast recovery indicates that with dimer separation
of about 9 A˚, active receptors were trapped in an unstable, stereochemically strained state. Notably,
the SG of V666C are 9 A˚ apart in a structure solved with the partial agonist NOW, which may repre-
sent a pre-open state (Yelshanskaya et al., 2014).
With desensitization blocked, AMPA receptors displayed a distinct trapping profile from that of
desensitized receptors (Figure 5C). All cross-linkers modulated active state less than the desensi-
tized in the first minute of exposure, apart from M8M (15 A˚; Figure 5B) and a fraction of active
receptors trapped with the shorter cross-linkers (M1M and M3M) recovered fast from the trap. The
trapping profile against linker length was sharper, indicative of less conformational heterogeneity.
At 12–15 A˚ (bMTSp, M6M and M8M), active receptors were trapped most effectively and without
fast recovery; at 18 A˚ (M10M) the extent of trapping decreased (Figure 5—source data 1). This pla-
ces the preferred V666C sulfhydryl separation in the active state around 15 A˚, somewhat closer than
19 A˚ obtained in the cryo-EM structure of active GluA2 (Figure 1C). The description of the trapping
profile by a parabola (with minimum at 13 A˚) was not as good as for the desensitized condition, with
the profound trapping by M8M being underestimated.
The generally reduced inhibition of active receptors, compared to desensitized ones, led us to
investigate the possibility that bis-MTS reagents modify non-desensitizing V666C receptors in other
ways than current amplitude reduction. We measured the rate of receptor deactivation before and
after the trap in M10M in the presence of desensitization blocker CTZ and found no difference (Fig-
ure 5—figure supplement 1C–D, tpre-trap = 1.7 ms ± 0.2, tpost-trap = 1.6 ± 0.2 ms, n = 8, p = 0.05
(paired randomization test)). We considered the possibility that non-desensitizing (CTZ bound)
receptors were modified by M10M in a functionally silent manner. We tested this scenario with the
following experiment: a patch with V666C receptors was first trapped in M10M and CTZ; CTZ was
then washed-out of the patch until V666C receptors were able to desensitize again freely (Figure 5—
figure supplement 1A (2)). After this, we exposed receptors to M10M and glutamate (Figure 5—
figure supplement 1A (3)). If non-desensitizing V666C receptors had been silently modified by
M10M, then a fraction of the receptors should have been protected resulting in the reduced sensitiv-
ity to further trapping by M10M. V666C receptors initially exposed to M10M in the presence of CTZ
were modified to the same extent as naı¨ve receptors (Ipeak post-trap/Ipeak pre-trap for V666C initially
trapped in CTZ: 0.23 ± 0.04, n = 6 and for V666C never trapped in CTZ: 0.30 ± 0.03, n = 16,
p = 0.07; Figure 5—figure supplement 1B). Taken together, these results strongly suggest that
non-desensitizing V666C receptors were not silently modified by M10M. Instead, the reduced inhibi-
tion of active receptors reflected state-dependent protection from modification. The effect of M10M
was inhibitory rather than potentiating, despite its length (18 A˚) matching closely the predicted
V666C separation of 19 A˚ (Figure 1C).
Auxiliary subunits do not alter the geometry of desensitized receptors
Trapping with bis-MTS cross-linkers so far indicated more conformational flexibility of the LBD layer
in desensitized than activated AMPA receptors. However, synaptic AMPA receptors are rarely
expressed alone and are instead associated with various auxiliary proteins that re-define their kinetic
properties (Schwenk et al., 2012; Jackson and Nicoll, 2011). We therefore wondered if the pres-
ence of auxiliary subunits, such as Stargazin (Stg), could affect conformational flexibility of AMPA
receptors.
Recently, cryo-EM structures of AMPA receptors in complex with auxiliary subunits have been
acquired in resting, active and desensitized states (Figure 1B) (Chen et al., 2017; Twomey et al.,
2017a). These structures all estimate reduced separation of V666C residues when compared to
receptors without auxiliary proteins. For example, sulfhydryl groups of V666C residues on subunits A
and C are 19 A˚ apart in the activated receptors without Stg and 15 A˚ in complex with Stg
(Figure 1C). In the desensitized state, the equivalent residues are 21 A˚ apart in homologous kainate
receptors (PDB: 5KUF [Meyerson et al., 2016]) and 17 A˚ in desensitized GluA2 receptors associated
Figure 4 continued
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Figure 5. The active LBD layer is dilated. (A) Current traces of trapping active V666C receptors. Cyclothiazide (CTZ) was included at 100 mM throughout
the experiment to block desensitization. The duration of the trapping pulse is indicated in green. For M3M, gray dots indicate recovery from trap
immediately after the trap (t = 2.0 ± 0.2 s, n = 8). Post- and pre-trap current amplitude was determined from the control pulses (arrows). (B) Summary of
bis-MTS trapping (1 min) of desensitizing (black) and non-desensitizing V666C receptors (green). Desensitizing data are from Figure 2E. p values
Figure 5 continued on next page
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with GSG1L auxiliary proteins (Figure 1C, PDB: 5VHZ [Twomey et al., 2017b]). If auxiliary subunits
keep the LBD layer more compact, we reasoned that their presence should also limit the effects of
longer bis-MTS cross-linkers. For example, the longest cross-linker (M10M) could be expected to
have less effect on the desensitized V666C receptors in the presence of Stg.
To test this hypothesis, we repeated the trapping experiments on complexes of AMPA receptors
with Stg (Figure 6). GluA2 and Stg were co-expressed and association of complexes was assessed
by measuring the ratio of kainate current over glutamate current (KA/Glu). The relative efficacy of
the partial agonist kainate is known to be higher for GluA2-Stg complexes than for GluA2 alone,
making it a good marker of GluA2-Stg association (Tomita et al., 2005; Shi et al., 2009). After
establishing formation of the GluA2 V666C-Stg complexes in the patch, we proceeded with the trap-
ping protocol that exposed complexes to glutamate and a bis-MTS cross-linker (1 mM) for 1 min
(Figure 6A–B), as described previously. No blocker of desensitization was added and the receptors
were allowed to desensitize freely. Stargazin reduces desensitization of AMPA receptors so the
crosslinking represents trapping across a mixture of active and desensitized states.
The trapping results summarized in Figure 6C show that the presence of auxiliary subunit Stg
apparently protected V666C receptors from cross-linking by bis-MTS. Indeed, following trapping, a
robust response was preserved, and could not be overcome by longer trapping intervals (Figure 6—
figure supplement 1A–B). Based on published structures, the decrease in the trapping extent was
expected for M10M (Figure 6C and Figure 6—source data 1), but not for shorter bis-MTS. This
result indicates the presence of alternative conformations that have a more compact extracellular
layer or that otherwise render cysteines inaccessible to modulation by bis-MTS.
To test whether bis-MTS cross-linkers perhaps act on non-complexed V666C receptors only, with-
out affecting V666C-Stg complexes, we measured the KA/Glu current ratio before and after the bis-
MTS trap for a series of patches. We reasoned that if only non-complexed V666C receptors were
being modified, the glutamate-activated current should reduce, but the kainate current (which is
almost entirely carried by GluA2-Stg complexes) should not. Therefore, preferential trapping of non-
complexed V666C mutants should lead to an increase in KA/Glu ratio. As shown in Figure 6E, the
KA/Glu ratio was not affected (before trap: 0.46 ± 0.03; after trap: 0.43 ± 0.02, n = 13; p = 0.2,
paired randomization test), indicating V666C-Stg complexes were being modified by bis-MTS cross-
linkers.
Stargazin maintains active receptors in a compact arrangement
The trapping profile of V666C-Stg complexes (orange in Figure 6D) reflects the partial protection
from trapping in the presence of Stg for all cross-linker lengths, but its overall shape is practically
superposable onto the trapping profile of desensitized V666C receptors without Stg (red, dashed
line in Figure 6D). Strikingly, the two curves reach their minimum at the same point of 11 A˚ (triangles
in Figure 6D) and have identical curvature. This indistinguishable length dependence indicated that
the trapping of V666C-Stg complexes came primarily from trapping desensitized receptors, and that
the active complexes of V666C-Stg might be untouched by bis-MTS cross-linkers.
To test this hypothesis, we repeated the trapping protocol in the presence of CTZ, to block
desensitization of V666C-Stg complexes. Two cross-linkers were tested in this condition: M1M, the
Figure 5 continued
compare the desensitizing and non-desensitizing condition. For p values comparing effects with and without bis-MTS and between the cross-linkers,
see Figure 5—source data 1. Bis-MTS length is indicated in brackets; ‘w/o MTS’: without MTS. (C) Trapping profile of active V666C receptors after the
first minute of exposure fit with parabola (green line), reaching the minimum (green triangle) at (13, 0.3). Trapping profile of desensitized receptors is
shown as a red, dashed line (parabola with minimum at 11 A˚, black triangle). (D) Dependence of the trapping time on the length of the bis-MTS. V666C
receptors were exposed up to six times to the trapping protocol described in (A). Current reduction was determined after each 1-min application to a
bis-MTS. Current decay was described with a monexponential fit (t in brackets).
DOI: https://doi.org/10.7554/eLife.40548.012
The following source data and figure supplement are available for figure 5:
Source data 1. Statistics of trapping active V666C receptors with different bis-MTS cross-linkers; data from Figure 5B.
DOI: https://doi.org/10.7554/eLife.40548.014
Figure supplement 1. No silent modification of active V666C receptors.
DOI: https://doi.org/10.7554/eLife.40548.013
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Figure 6. Stargazin attenuates effects of bis-MTS cross-linkers. (A) Current traces of V666C trapping in M3M, without (top) and with Stargazin (Stg;
bottom). Legend is the same as in Figure 2, with a trapping pulse shown here in orange. (B) Same as in (A), but for M10M. (C) Trapping effects for
V666C without (black) and with Stg (orange). Post- and pre-trap peak current was determined from the control pulses (arrows in (A) and (B)). Data
without Stg are the same as in Figure 2D. p values compare the effects of the respective cross-linker with and without Stg. For statistics vs. w/o MTS
Figure 6 continued on next page
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shortest one, and M8M, which had one of the strongest trapping effects on active V666C receptors
without Stg (Figure 5B–C). As predicted, neither bis-MTS cross-linker had any effect on activated
GluA2-Stg complexes (M1M: p = 0.1, n = 9; M8M: p = 0.2, n = 9; paired recordings with and without
bis-MTS) (Figure 7). Over very long exposures, M8M could induce irreversible inhibition, presumably
from residual desensitization (Figure 6—figure supplement 1). This result confirmed that partial
trapping observed for desensitizing V666C-Stg mainly derived from bis-MTS cross-linkers accessing
desensitized complexes.
We next wondered if the protection from trapping observed for active GluA2-Stg complexes
could, at least partly, be explained by reduced accessibility of cysteines during exposure to bis-MTS,
perhaps because the Cys666 residues are buried against other subunits or oriented such that the
sulfhydryl groups are inaccessible for cross-linking. We mined possible conformations of the active
LBD tetramer (PDB: 5WEO) using a coarse docking approach, allowing each active dimer to move in
the membrane plane, and allowing rotation of one dimer with respect to the other around axes par-
allel and perpendicular to the active dimer interface (Figure 7D and E). Interestingly, docked struc-
tures with low Cys666 accessibility segregated into two classes, a loose arrangement where Cys666
were physically close but sterically hindering each other (with the centre of mass separation of the
two active dimers comparable to 5WEO, for example models m17 and m32 in Figure 7D), and a
tighter arrangement of the LBDs with V666C close to helix K (with the centre of mass separation of
the two active dimers smaller than in 5WEO, for example m223 and m265 in Figure 7D), not unlike
the structure of the V666C mutant LBD bound with fluorowillardine (5JEI) (Salazar et al., 2017). In
that structure, additional shielding of the V666C side chain is afforded by its being shielded by
neighboring structural elements.
Thus, docked structures lead us to hypothesize that active GluA2-Stg complexes could avoid
cross-linking not just by adopting more compact LBD arrangements, but also by preferring confor-
mations which shield V666C SG groups.
Discussion
Technical advances in cryo-electron microscopy have revolutionized the study of membrane proteins,
and the supply of structural information is greater than ever before. However, as the catalogue of
images swells, the need to relate their geometry to dynamics becomes more pressing. In case of
AMPA receptors, full-length structures in complexes with various ligands and auxiliary subunits have
been published. Here, we have used a classical crosslinking approach allied to rapid perfusion to
measure distances up to 18 A˚ in AMPA receptor extracellular domains across different functional
states and in the time domain.
Bis-MTS cross-linkers have been used previously to aid identification of movements underlying
state transitions in AMPA and NMDA receptors (Armstrong et al., 2006; Tajima et al., 2016). Here,
we report effects with a strong dependence on the target site, length of the cross-linker, functional
state of the receptor and the presence or absence of auxiliary subunits. Since most bis-MTS cross-
linkers are alkyl chains and hence flexible, they can cross-link pairs of Cys residues closer to each
other than the extended length of the cross-linker. For example, M10M could cause the same effect
Figure 6 continued
and between cross-linkers, see Figure 6—source data 1. (D) Trapping profile of desensitizing V666C + Stg complexes. The data were fit with a
parabola (orange line); the fit reaches minimum (orange triangle) at (11, 0.3). Trapping profile of desensitized receptors without Stg is shown as red,
dashed line (parabola with minimum at (11, 0.1); black tringle). (E) The kainate/glutamate (KA/Glu) peak current ratio was determined for each patch
before and after trapping with a bis-MTS (similar to the experimental design in Figure 3A–C with 1 mM KA and 10 mM Glu in 1 mM DTT). V666C + Stg
KA/Glu measurements before and after trap shown here are paired recordings, pooled for various bis-MTS cross-linkers.
DOI: https://doi.org/10.7554/eLife.40548.015
The following source data and figure supplement are available for figure 6:
Source data 1. Statistics of trapping V666C receptors with Stargazin (Stg) with different bis-MTS cross-linkers; data from Figure 6C.
DOI: https://doi.org/10.7554/eLife.40548.017
Figure supplement 1. Cross-linking times depend on the length of the bis-MTS cross-linker, functional state of the receptor and the presence
Stargazin.
DOI: https://doi.org/10.7554/eLife.40548.016
Baranovic and Plested. eLife 2018;7:e40548. DOI: https://doi.org/10.7554/eLife.40548 15 of 26
Research article Neuroscience Structural Biology and Molecular Biophysics
when bound to two Cys that are 7 or 15 A˚ apart, acting as a universal inhibitor for a range of Cys dis-
tances. For this reason, we used bis-MTS ranging from 7 to 18 A˚ in length (M1M – M10M). Our
results show an optimum (inhibitory) effect of the cross-linkers at position V666C, with M10M not
producing as strong effect as shorter cross-linkers. This is inconsistent with the interpretation of the
universal inhibitor and suggests bis-MTS cross-linkers exert their effect mainly by preventing the
engineered residues from separating more than the extended length of the cross-linker. We also
tested a rigid cross-linker, bMTSp, whose length matches closely that of flexible M6M (12 and 13 A˚,
Figure 7. Stargazin blocks access to bis-MTS cross-linkers in the active state. (A) Traces showing trapping by M1M in the active state in the absence
(black) and presence (blue) of Stargazin (Stg). Legend is the same as in Figure 2, with a trapping pulse shown here in blue. Desensitization was blocked
by CTZ (100 mM) present throughout the experiment. Glutamate (Glu) was 10 mM and DTT 1 mM. (B) Same as in (A), but for M8M cross-linker. (C)
Summary of the trapping effects for M1M and M8M in the active state in the absence (black) and presence (blue) of Stg. Pre- and post-trap current was
determined from control pulses as indicated by arrows. (D) Putative compact structures that could protect from bis-MTS modification. Results of 268
runs of rigid body docking of LBD dimers against each other, to minimize Cys666 access in subunit A and mimic the protection from crosslinking.
Results from known structures (5JEI, 4YU0 loose, 4YU0 tight and 5WEO, diamonds a-d) and four of the generated models – m17, m32, m223, and m265
- segregate into two classes, similar to the loose (SG-SG distance between subunits < 10 A˚) and tight arrangements (SG-SG distance > 20 A˚, C666 SG
buried close to helix K) (Baranovic et al., 2016). The symbol size corresponds to the dimer centre of mass separation and the color to the number of
atom clashes (distance < 2.2 A˚.) For reference, dimer centre of mass separations of known structures are: 5JEI, 44 A˚; 4YU0 loose, 47 A˚; 4YU0 tight, 47 A˚
and 5WEO, 52 A˚. Note that m17 is selected from a cluster of models with zero clashes (cyan), but adjacent in the graph to two other models with
clashes (red circles). (E) LBD arrangements in four models marked on the graph in panel D and the original seed for each optimization, the glutamate
bound LBD tetramer from 5WEO full-length GluA2 structure with Stg.
DOI: https://doi.org/10.7554/eLife.40548.018
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respectively). This places a lower limit on separation of V666C Cys at ~12 A˚. The only difference we
observed between bMTSp and M6M was with intra-dimer K493C mutant, with M6M blocking desen-
sitization more effectively than bMTSp, perhaps indicating an angle between the K493C side chains
that was more easily accommodated by the flexible chain.
All bis-MTS cross-linkers, when applied to the mutants at the inter-dimer LBD interface, inhibited
the current, albeit to a different degree depending on the functional state of the receptors. Whereas
cross-linking of the desensitized states should result in current inhibition, cross-linking of an open
channel would be expected to result in more active receptors. However, to date all inter-dimer traps
have been inhibitory. Inhibition seems independent of the nature of the constraint, whether disul-
phide bonds (Plested and Mayer, 2009; Yelshanskaya et al., 2016), metal bridges (Lau et al.,
2013; Baranovic et al., 2016), flexible or rigid bis-MTS cross-linkers (this study). In addition, a struc-
ture of the full-length GluA2 receptor carrying a gain-of-function mutation and in complex with a
partial agonist, blocker of desensitization and a peptide constraining the LBD dimers resulted in a
closed channel (Chen et al., 2014). Cysteine crosslinks within dimers inhibit the gating of kainate
receptors, even when blocking desensitization (Daniels et al., 2013). Whereas the peptide binding,
zinc and disulphide bridges only form under strict geometrical requirements, possibly incompatible
with a stably open pore, the same cannot be said for bis-MTS cross-linkers. The cross-linkers are flex-
ible and therefore do not restrict the trapped LBD tetramer to a single geometry. The inhibitory
effect of the crosslinkers is not universal – at the active intra-dimer interfaces we could potentiate
receptors as shown previously (Armstrong et al., 2006). Structural models of full-length AMPA
receptors in various states of activity do not explain why every restraint of the LBD dimers leads to a
decrease in activity. Either the correct sites for potentiation have not yet been found, or this obser-
vation reflects a mechanistic detail of receptor activation. The mechanism behind this inhibition
remains frustratingly unclear, limiting the interpretation of the cross-linking approach used in this
study.
In Figure 8A–B, the trapping profiles of V666C receptors with the available structural models of
GluA2 in the equivalent condition are compared. The shallow trapping profile of desensitized AMPA
receptors indicates a structural ensemble of conformations broadly in agreement with multiple
desensitized states (Meyerson et al., 2014; Robert and Howe, 2003). Even though the LBD dimer-
dimer separation observed in the model (> 18 A˚, EMDB: 2688) was not tested with the bis-MTS
cross-linker of the corresponding length, extrapolation of the trapping profile indicates such confor-
mations are available to desensitized AMPA receptors. However, the longest cross-linker (18 A˚) was
the slowest one to act on desensitized receptors, indicating that this conformation, and more ‘open’
ones, are not readily available for cross-linking, but slowly get populated during prolonged expo-
sures to agonist. The longest cross-linker, M10M, was also the slowest one to act in the active state.
There, the strongest cross-linking effect was achieved by the 12–15 A˚-long bis-MTS (green in
Figure 8B). This suggests inter-dimer V666C residues are closer together in the active state than 19
A˚, predicted by the structural model (PDB: 4UQ6). The extracellular layer was also seen in an
‘opened’ arrangement in NMDA receptors (Zhu et al., 2016), with the caveat that these structures
were antagonist-bound and therefore not equivalent to our observations.
The presence of Stg lead to universal attenuation of the cross-linking effect, for all bis-MTS
lengths and both functional states, desensitized and active (orange and blue in Figure 8A and B,
respectively). The longest crosslinker (M10M) produced the least trapping, even following long
exposures (~3 min). Thus, the LBD layer could not be modulated by bis-MTS cross-linkers for major-
ity of these receptors. This result chimes with structural and FRET experiments (Shaikh et al., 2016),
where the presence of Stg made the LBD and ATD layer more compact. In the desensitized state,
the shape of the trapping profile is the same, with or without Stg (Figure 8A), with both parabola
reaching a minimum point at 11 A˚ (triangles in Figure 8A). This is in excellent agreement with the
structure of desensitized GluA2-Stg complex (PDB: 5VOV). In the active state with Stg, our results
deviate from the available full-length active structures. Both short and long (7 or 15 A˚) bis-MTS
reagents failed to inhibit currents in the first minute of trapping, indicating more compact LBD
arrangements over this timescale than obtained in the structures. In other words, if structures can be
obtained in a time-resolved manner in milliseconds following glutamate exposure (Unwin, 1995),
our results suggest they should be more compact than structures solved to date.
The protection from trapping in our cross-linking experiments most likely has multiple origins.
Although ‘protection’ could result from a persistent long-distance separation, outside the range of
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Figure 8. The presence of Stargazin and short agonist exposures keep the agonist-bound LBD layer compact. (A) Trapping profiles for V666C in
desensitized states, without (red) and with (orange) Stargazin (Stg). Solid lines are fit parabola, with local minima indicated as triangles. The right
handside of the x-axis is marked as > 18 A˚, as the resolution of the only available desensitized structure without auxiliary subunits is too low to measure
residue distances. Vertical, dashed, black lines indicate V666C sulfhydryl separation in the respective structure (PDB accession codes in brackets).
Names of structures are color-coded same as the trapping profiles. (B) Same as in (A), but for active state without (green) and with Stg (orange). 4YU0 is
a structure of soluble, isolated LBDs. Quis: quisqualate (full agonist), RR: (R, R)  2b (Kaae et al., 2007) and LY: LY451646 (both desensitization
Figure 8 continued on next page
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the crosslinkers, several observations and common sense speak against this possibility. First, we pre-
viously showed that active receptors could be trapped by zinc bridges in compact arrangements
(Baranovic et al., 2016). Second, the long distance would have to be maintained throughout the
exposure, because any transit between compact and dilated arrangements must pass through inter-
mediate separations, allowing crosslinkers to span the gap, assuming extremely rapid reactivity of
the bis-MTS compounds (Kenyon and Bruice, 1977). Our reaction rates are close to the maximum
expected (105 M–1s–1; Liu et al., 1997). Third, even the most dilated structures are in the range of
crosslinker lengths that we used. Fourth, the mixed trapping condition for GluA2-Stg complexes in
the absence of CTZ apparently supports desensitized state trapping over a wide range of geome-
tries but no additional active state trapping. We cannot discount specific, state-dependent protec-
tion from crosslinking, produced by a unique, closed-cleft LBD conformation provoked by Stg in the
active state, but it seems to us unlikely. We reasoned that protection from crosslinking could, at least
partly, be accounted for by reduced accessibility of cysteine residues during exposure to bis-MTS.
Docking data in Figure 7D–E show that conformations which reduce the accessibility of the V666C
side chains are indeed accessible to the active LBDs. These arrangements are more compact than
the available structures of the full-length receptor in the active state (Chen et al., 2017;
Twomey et al., 2017a).
No matter how avid and complete trapping is, a possible source of receptor activity after trap-
ping is the activity of free (non-crosslinked) subunits (Figure 8—figure supplement 1). Based on the
GluA2 structural models, bis-MTS compounds cross-link subunits proximal to the central twofold
symmetry axis at the LBD level (subunits A and C), while sparing the distal subunits, B and D
(Figure 1A–C). In AMPA receptors without Stg, with desensitization blocked, the activity of only two
subunits produces subconductance openings with short open times (Rosenmund et al., 1998). But
the presence of Stg (Coombs et al., 2017; Zhang et al., 2014) increases the current carried by
receptors with one or two active subunits. In our experiments, Stg had an indefatigable effect of
maintaining receptor activity in the limit of long exposures to bis-MTS. The effect of Stg was inordi-
nately large, with a maximum effect of the crosslinking leaving approximately half the receptor activ-
ity unscathed. Can the two non-crosslinked subunits (B and D) produce this level of activity? A
simple back-of-the-envelope calculation suggests this effect is larger than expected. Single channel
recordings of GluA2 with Stg reveal that the conductance from two subunits, with desensitization
blocked, should be on average about 40% of a full opening but with Popen < 1 (Coombs et al.,
2017). Therefore, residual activity of the non-crosslinked subunits is higher than expected, unless
the B and D subunits have a predominant role in driving channel gating (as proposed from structural
studies [Sobolevsky et al., 2009]).
Physiological activation and desensitization of AMPA receptors takes place on a millisecond time-
scale. The fast gating contrasts desensitized states trapped by bis-MTS cross-linkers that take tens
of minutes to recover. It seems reasonable to assume that the degree of stabilization by different
crosslinkers is similar, and that the difference in stability comes from the states themselves. This idea
is supported by the cut-off that we observe – for crosslinkers longer than 10 A˚, crosslinking in desen-
sitized states is irreversible over 10 min (also in fivefold higher concentration of the reducing agent).
It is possible that upon cross-linking, V666C residues adopt conformations that make them inaccessi-
ble to the reducing agent, but this would then have to be highly specific for bis-MTS reagents longer
than 9 A˚ and state-specific (due to much faster recovery rates of active than desensitized receptors
after trapping in M1M or M3M). In addition, in reducing conditions, AMPA receptors recover from
disulphide crosslinking at the same sites in hundreds of milliseconds (Lau et al., 2013; Salazar et al.,
2017). Assuming that the length of the bis-MTS cross-linkers reflects level of structural
Figure 8 continued
blockers). (C) Schematic summarizing the bis-MTS cross-linking results. Color-code same as in Figure 1; ATDs are omitted. Black spheres represent
bound glutamate. Upper row: in the absence of Stg, GluA2 receptors access ‘open’ LBD conformation (black arrows) upon long exposures to agonist.
Bottom row: presence of Stg limits ‘opening’ of the LBD layer even at longer agonist exposures.
DOI: https://doi.org/10.7554/eLife.40548.019
The following figure supplement is available for figure 8:
Figure supplement 1. Cartoon depicting cross-linking (paperclips) of A-C subunits (green and blue), while B-D subunits are left free (red and yellow).
DOI: https://doi.org/10.7554/eLife.40548.020
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rearrangements and following the trend plotted in Figure 4H, this suggests that AMPA receptors at
synapses, exposed to brief glutamate transients and in complex with auxiliary subunits, are unlikely
to undergo extreme conformational changes. Considering that all of the experiments presented
here were done with over-expressed receptors and auxiliary subunit Stg, it is possible that V666C-
Stg complexes had variable stoichiometry of association, depending on the expression level. This
could impact how Stg affects conformational dynamics of the receptors, but a detailed investigation
of this is beyond the scope of this work. We note, however, that the presence of two copies of auxil-
iary subunit GSG1L were sufficient to keep the LBD layer compact in structural experiments
(Twomey et al., 2017b).
Long agonist exposures of minutes to hours are standard in structural biology experiments and
could, thus, contribute to the prevalence of more ‘open’ conformations in full-length structures with-
out auxiliary subunits (Figure 8C). However, long exposures to agonists are at odds with synaptic
conditions where AMPA receptors see glutamate on a millisecond timescale, before it is actively
cleared by transporters (Clements, 1996). Furthermore, any large structural rearrangements of the
extracellular domains would need to be accommodated by the crowded synaptic environment
(High et al., 2015; Tao et al., 2018) and potential presynaptic interaction partners (Saglietti et al.,
2007; Elegheert et al., 2016). When in complex with auxiliary subunits, no functional state of AMPA
receptors necessitates large domain movements, and compact arrangements of the extracellular
layer can sustain the gating process. We conclude that extracellular domains of synaptic AMPA
receptors are unlikely to undergo large structural rearrangements during synaptic transmission and
instead work in a fairly compact conformational regime, unless faced with long exposures to gluta-
mate in pathological conditions.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation
Source or
reference Identifiers
Additional
information
Cell line
(Homo sapiens)
HEK293 RRID: CVCL_0045 ACC No. 305 Obtained from
Leibniz
Forschungsinstitut
DSMZ
(Deutsche
Sammlung von
Mikroorganismen
und Zellkulturen
GmbH, Germany).
Transfected
construct
(Rattus norvegicus)
GluA2; GluA2flip Other ID_GenBank:
M38061.1
Gift from Mark Mayer
(NIH); vector: pRK5
with IRES eGFP,
unedited (Q) at the
pore site, signal
peptide: 21 amino acid.
Transfected
construct
(Mus musculus)
Stargazin; Stg Other ID_GenBank:
NM_007583.2
Gift from Susumu
Tomita; vector:
pRK5 with IRES dsRed
(dsRed_Max Addgene
plasmid: 21718).
Commercial
assay or kit
Nucleobond
Xtra Midi EF
Macherey and Nagel 740420.5 Plasmid DNA
preparation kit.
Chemical
compound,
drug
Bifunctional methanethiosulfonate
cross-linkers;
bis-MTS
Toronto
Research
Chemicals,
North York,
Canada
M1M: M258800;
M3M: P760350;
M6M: H294250;
bMTSp: P193250;
M8M: O235850;
M10M: D210875
Obtained as powder,
stock prepared in
DMSO, used
at final
concentration of
1 mM or 50 mM,
as indicated.
Continued on next page
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Continued
Reagent type
(species) or resource Designation
Source or
reference Identifiers
Additional
information
Chemical
compound,
drug
Monofunctional
methane
thiosulfonate
linker; MTSEA
Toronto Research
Chemicals,
North
York, Canada
MTSEA: A609150 Obtained as powder,
stock prepared in
DMSO, used at final
concentration of 1 mM.
Chemical
compound,
drug
Cyclothiazide; CTZ Hello Bio,
Bristol, UK
HB0221 Obtained as powder,
stock prepared in
DMSO, used at final
concentration of 100 mM.
Chemical
compound, drug
Kainate; KA Abcam plc,
Cambridge, UK
ab120100 Obtained as powder,
stock prepared in
Ringer, used at final
concentration of 1 mM.
Software,
algorithm
Docking Source: https://github.com/aplested/
cystance (copy archived at
https://github.com/
elifesciences-publications/cystance);
this paper (Plested, 2018)
Python script for
PyMOL and CCP4.
Software,
algorithm
Randomization
test
Source: https://
github.com
/aplested/DC-Stats (copy archived at
https://github.com/
elifesciences-publications/DC-Stats);
DC-Stats suite (Plested and Lape, 2018)
10^5 iterations
performed for each test.
Molecular biology
In all experiments, the unedited (Q586) GluA2flip version of rat GluA2 gene was expressed from the
pRK5 vector. Amino acid numbering refers to the mature receptor assuming a signal peptide of 21
amino acids in length. As a marker of transfection, eGFP was expressed from the same vector,
downstream from an internal ribosomal entry sequence (IRES). Mouse Stargazin gene (a kind gift
from Susumu Tomita) was expressed from a separate pRK8 vector containing IRES-dsRed
(Carbone and Plested, 2016). All mutations were introduced by overlap PCR and confirmed by dou-
ble-stranded sequencing.
Cell culture and transfection
GluA2 constructs were expressed transiently in HEK293 cells using calcium-phosphate precipitation
or PEI method as described previously (Baranovic et al., 2016; Riva et al., 2017). HEK293 cells
were obtained from the Leibniz Forschungsinstitut DSMZ (Deutsche Sammlung von Mikroorganis-
men und Zellkulturen GmbH, Germany) ACC no. 305 (RRID: CVCL_0045) and tested negative for
mycoplasma. Cells were maintained in MEM Eagle medium (PAN-Biotech GmbH, Aidenbach, Ger-
many) supplemented with 10% (v/v) fetal bovine serum and antibiotics (penicillin (100 U/mL) and
streptomycin (0.1 mg/mL; PAN-Biotech).
For transfections, 2–3 mg of DNA was transfected per 35 mm dish and cells were washed after 6–
8 hr. Recordings were performed 24–72 hr after the transfection at room temperature. For transfec-
tions with Stargazin, Stargazin DNA was co-transfected with GluA2 DNA at 2:1 mass ratio and after
the transfection, cell medium was supplemented with 40 mM NBQX to reduce Stargazin-induced
cytotoxicity.
Solutions
Chemicals were obtained from Sigma Aldrich (Munich, Germany), Abcam plc (Cambridge, UK) and
Hello Bio (Bristol, UK). MTS compounds were obtained from Toronto Research Chemicals (North
York, Canada).
The internal (pipette) solution for recordings without Stargazin contained (mM): 115 NaCl, 1
MgCl2, 0.5 CaCl2, 10 NaF, 5 Na4BAPTA, 10 Na2ATP, 5 HEPES, titrated to pH 7.3 with NaOH. For
recordings with Stargazin, the internal solution was slightly modified: 120 NaCl, 0.5 CaCl2, 10 NaF, 5
Na4BAPTA, 5 HEPES and 0.05 spermine, pH 7.3. The external recording solution in all experiments
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contained (mM): 150 NaCl, 0.1 MgCl2, 0.1 CaCl2 and 5 HEPES, pH 7.3. Different drugs were added
to the external solution as needed. Glutamate was always applied at 10 mM and DL-dithiothreitol
(DTT) at 1 mM. Cyclothiazide (CTZ) and kainate (KA) were thawed from stock solutions on the day of
the experiment. Final CTZ and KA concentrations in all experiments were 100 mM and 1 mM,
respectively.
All MTS compounds were obtained as powder. Although monofunctional MTS reagents are
known to be highly reactive and unstable in aqueous solutions (Kenyon and Bruice, 1977), this infor-
mation is lacking for bifunctional cross-linkers used in this study. Hence, we took special care to mini-
mize exposure of bis-MTS compounds to oxidizing (aqueous) solutions (Takatsuka and Nikaido,
2010). The powder was dissolved in DMSO, aliquoted and kept on ice on the day of the experiment.
Once a stable patch recording was obtained, an aliquot was dissolved in external solution to a final
concentration of 1 mM and applied to the patch. This way, aqueous bis-MTS solutions were on aver-
age 2–3 min old at the moment of application. Each MTS stock was tested with GluA2 wild-type
receptors and K493C receptors as negative and positive controls, respectively. The final MTS con-
centration of 1 mM was chosen based on previous work (Sobolevsky et al., 2003; Yelshansky et al.,
2004). We avoided higher concentrations of MTS compounds due to potential cross-reactivity and
chaining effects.
Patch clamp electrophysiology
Ligands and drugs were applied to outside-out patches via a custom made 4-barrel glass (VitroCom,
USA) mounted to a linear piezo–electric wafer (PiezoMove P-601.4, PI, Germany) (Lau et al., 2013).
Two barrels were perfused with control solutions and the third barrel with the trapping solution, as
described below. All patches were voltage clamped at  40 mV unless stated otherwise. Currents
were low-pass filtered at 10 kHz ( 3 dB cut-off, eight-pole Bessel filter) using an Axopatch200B
amplifier (Molecular Devices, USA) and acquired with AxographX software (Axograph Scientific, Aus-
tralia, RRID:SCR_014284) at 20 kHz sampling rate via Instrutech ITC-18 digitizer (HEKA, Germany).
Current traces were digitally filtered at 1 kHz (low-pass) for presentation in figures.
To assess the effect of different bifunctional cross-linkers on AMPA receptors, the receptors were
exposed to the cross-linker (1 mM) for 1 min. Before and after this trapping exposure, the current in
the patch was tested with control pulses that contained only 10 mM glutamate, without the cross-
linker and in the presence of DTT (1 mM) as a reducing agent (Figure 2A–C). Four control pulses
before application of the cross-linker provided a measure of the patch current before any exposure
to the cross-linker. Accordingly, (up to thirty) control pulses recorded after the MTS application,
were used to assess any changes in the patch current imparted by the cross-linker treatment.
For recordings of GluA2 receptors co-expressed with auxiliary subunit Stargazin, care must be
taken that GluA2 receptors are indeed associating with Stargazin. One strategy to minimize the
presence of lone V666C receptors relies on the relief of spermine (polyamine) block at positive vol-
tages imparted by complexation with Stargazin (Carbone and Plested, 2016). Although we have
included spermine in the pipette solution and measured relieve of block for each patch, we did not
perform recordings at positive voltages, as the currents were not stable enough during minutes-long
trapping protocols. Instead, a change in kainate efficacy was used as a marker of GluA2-Stargazin
association as described in the text.
Analysis
Trapping effects were quantified as the ratio of the average current after the trap (determined from
the second post-trap control pulse) and average current before the trap (determined from the four
pre-trap control pulses; arrows in Figure 2A–C):
Active fraction ¼
Ipost trap
Ipre trap
In case of desensitizing receptors, peak current was measured and in the case of non-desensitiz-
ing receptors, steady-state current.
The trapping time of each cross-linker (at 1 mM) was determined from cumulative exposures to a
bis-MTS of up to 6 min (six repetitions of the 1-min trapping protocol). After each application, cur-
rent reduction was determined with respect to the initial current in the patch, before any trap. The
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resulting current decay was described by a monoexponential fit in Igor Pro (v7.06, Wavemetrics,
Lake Oswego, Oregon, USA, RRID:SCR_000325). This approach most likely overestimates the time
M3M and M6M need to trap the V666C receptors, as majority of the current is inhibited within the
first minute of exposure to bis-MTS (Figure 2F). For the experiments with 50 mM bis-MTS (M3M and
M10M, Figure 3), where faster trapping rates are expected, the experiment was redesigned to mea-
sure the peak current inhibition every 50 ms, rather than in 1-min intervals.
To determine the rate of recovery from trapping by MTS cross-linkers, the number of post-trap
control pulses was increased until full recovery was attained. An envelope of post-trap peak current
responses was then created in Igor Pro and fit with a monoexponential. This approach was possible
only for faster recovery rates, on the time scale of seconds, such as recovery of desensitized V666C
receptors from trapping with M1M (Figures 2B and 4D) and from direct V666C sulfhydryl cross-links
(Figure 4H) and recovery of active V666C receptors from trapping with M1M and M3M (Figure 5A).
With longer bis-MTS cross-linkers, the recovery time increased from seconds to minutes, making
direct measurements of the recovery time from post-trap control pulses impractical. Instead, the
experimental design was re-adjusted to allow measurements of long recovery times as described in
Figure 4A–C. In brief, peak current in the patch was initially recorded with 100 ms jumps into gluta-
mate in control conditions until it stabilized. Then, a trapping protocol was performed as described
above, with control pulses before and after the trap. After the trapping protocol, the current in the
patch was again monitored, for about 10 min, with fast control jumps into glutamate in order to fol-
low any potential recovery of the peak current. In this time period, desensitized V666C receptors
managed to recover only from trapping by M1M and M3M (Figure 4D–G), in which case the recov-
ery was fit with a monoexponential.
Trapping profiles (Figures 2G and 6D) were fit with a parabola in Igor Pro:
f xð Þ ¼ K0þK1 x K2ð Þ
2
where K1 defines the curvature, K0 the minimum effect and K2 the x value at the minimum. Data
points were weighted by the standard error of the mean for the fit.
Computational docking
To investigate structures of the LBD tetramer that could preclude trapping by blocking access to the
Cys666 SG moiety, we treated each dimer as a rigid body and subjected them to rotations and
translations in the membrane plane. Python scripts (available at https://github.com/aplested/cys-
tance; copy archived at https://github.com/elifesciences-publications/cystance) were written as a
glue for molecular manipulations in PyMOL and CCP4 (RRID:SCR_007255) functions to measure
geometry and exposure of the cysteine (AREAIMOL, NCONT (Winn et al., 2011)). For each run, trial
arrangements that reduced Cys666 SG accessibility in subunit A whilst also keeping the dimers in
close proximity (with minimal atom clashes) and maintaining physiologically plausible in-plane linker
arrangements were retained as seeds for subsequent rounds, and the step size was reduced. Trial
arrangements with more than 10 atom clashes (< 2.2 A˚) were rejected. No refinement was done to
eliminate spurious clashes from flexible surface residues. The optimization was ended when no fur-
ther improvement was possible. Each search lasted about 5–10 min on a 2017 Macbook Pro.
All p values were determined by non–parametric randomization test (non–paired, unless stated
otherwise), using at least 105 iterations (DC-Stats suite: https://github.com/aplested/DC-Stats). Bars
in graphs indicate mean and error bars SEM.
Structural models and related measurements were visualized and measured in PyMOL (v2.0,
RRID:SCR_000305) (The PyMOL Molecular Graphics System, Version 2.0 Schro¨dinger, LLC). The
length of bis-MTS cross-linkers was measured in ChemDraw Professional (PerkinElmer, USA.).
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